Curevac N.V. (CVAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 63,277 | 1,413 | 941 | 7,044 | 543,095 |
| Cost of Goods | 438 | 2,511 | 922 | 1,285 | 24,115 |
| Gross Profit | 62,839 | -1,098 | 19 | 5,759 | 518,979 |
| Operating Expenses | -299,325 | 69,506 | 58,595 | 59,962 | 114,025 |
| Operating Income | 362,603 | -70,094 | -57,655 | -53,918 | 405,070 |
| Interest Expense | 6,919 | 641 | 351 | 206 | 155 |
| Other Income | 3,846 | 2,662 | 3,587 | 5,794 | 2,567 |
| Pre-tax Income | 359,530 | -68,073 | -54,419 | -48,331 | 407,481 |
| Income Tax | 40,153 | -461 | 452 | -6,842 | 35,769 |
| Net Income Continuous | 319,377 | -67,613 | -54,871 | -41,489 | 371,712 |
| Net Income | $319,377 | $-67,613 | $-54,871 | $-41,490 | $371,712 |
| EPS Basic Total Ops | 1.41 | -0.30 | -0.24 | -0.20 | 1.66 |
| EPS Basic Continuous Ops | 1.41 | -0.30 | -0.24 | -0.19 | 1.66 |
| EPS Diluted Total Ops | 1.41 | -0.30 | -0.24 | -0.19 | 1.65 |
| EPS Diluted Continuous Ops | 1.41 | -0.30 | -0.24 | -0.18 | 1.65 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.30 | -0.24 | -0.15 | 1.65 |
| EBITDA(a) | $368,001 | $-64,715 | $-52,832 | $-49,515 | $410,258 |